Position in COGT
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$3,899,190
+$2,256,035 QoQ
Shares Held
101,304
+119.0% QoQ
Ownership
0.059%
of shares outstanding
% of Portfolio
0.65%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2025
2 quarters on record
Voting authority
Sole 63%
Shared 0%
None 37%
Common Shares in COGT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Pier Capital, LLC holds $20,446,999 across 6 Biotechnology names. COGT ranks #3 (19.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ROIV |
Roivant Sciences Ltd.
|
227,093 | $6,290,476 | |
| 2 | CYTK |
Cytokinetics Inc
|
69,583 | $4,586,215 | |
| 3 | COGT |
Cogent Biosciences, Inc.
This page
|
101,304 | $3,899,190 | |
| 4 | GPCR |
Structure Therapeutics Inc.
|
47,551 | $2,291,958 | |
| 5 | OLMA |
Olema Pharmaceuticals, Inc.
|
136,108 | $2,029,370 | |
| 6 | CAPR |
Capricor Therapeutics, Inc.
|
44,401 | $1,349,790 |
All Filings in COGT
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $3,899,190 | 101,304 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $1,643,155 | 46,260 | Shares | Sole | 2026-02-03 | |
| No filing history on record for this holder in this stock. | ||||||